Search Results for "Viropro International Montreal"
Original Source: Viropro, Inc.
Viropro, Inc. conducts its operations through its subsidiaries Viropro International, Inc. and Biologics Process Development, Inc. The Company's principal objective and mission is to "make biotech drugs for its clients, efficiently and economically." Towards this end, the Company specializes in the use of its Intellectual Property and high-yield manufacturing process technologies, for industrial-scale production of biopharmaceutical drugs for its clients that...
Matching Channels
College Hill - international business communications consultancy
College Hill is a growing international business communications consultancy with offices in Europe, China, India, South Africa and the United States. College Hill's wide range of complementar...
Able to take advantage of a €2 European funding stimulus in 2009, the Czech Republic is one of Europe's top 5 centers for biotechnology companies. In just over decade, the Czech Republic ha...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in term...
GMO Crops - news, views, reports
Transgenic plants have been engineered to possess several desirable traits, such as resistance to pests, herbicides, or harsh environmental conditions, improved product shelf life, and increased nut...
The Top 10 Medical Device Companies
Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in...
Matching News
Oncobiologics and Viropro Announce Emerging Markets Biosimilars Deal
Washington, DC and Cranbury, NJ – February 25, 2013 — Viropro, Inc. (OTC: VPRO) and Oncobiologics, Inc. announced today the signing of a biosimilar collaboration agreement. Under the agree...
GL Rapha and Viropro, Inc. Announce Signing of Memorandum of Understanding
May 10th 2013 SEOUL, KOREA & BUFFALO, NY, USA - LRapha and Viropro, Inc. announced that the two companies entered into a Memorandum of Understanding that sets the groundwork for close co...
CoreRx, Viropro sign reciprocal referral deal to advance new medicines
CoreRx, a provider of preformulation, formulation and development services, and Viropro have signed a reciprocal referral agreement.
Oncobiologics and Viropro make biosimilar deal
US-based Oncobiologics and monoclonal antibody developer Viropro announced on 25 February 2013 that they had signed a biosimilar collaboration agreement between the two companies.
Pharmaceutical Takeover: Montreal-Based Valeant to Buy Arizona's Medicis
From Canadian Press DataFile (September 3, 2012) MONTREAL -- Quebec-based Valeant Pharmaceuticals International, Inc. (TSX:VRX) is acquiring Medicis Pharmaceutical Corporation of Scottsdale, Ariz., to...
Sport makes middle-aged people smarter
(University of Montreal) High-intensity interval training makes middle-aged people not only healthier but smarter, showed a Montreal Heart Institute (MHI) study led by Dr. Anil Nigam of the MHI and Un...
Viropro, Oncobiologics in Biosimilars Pact
Aims to commercialize six products in emerging markets
Matching PubMed Articles
Tachycardia in a Patient with Hypertrophic Cardiomyopathy and Suspected Ventricular Preexcitation.
Tadpole cells in an unstained urine sediment.
Blocking the terminal complement complex: Mismatch and misconception.
The case for mini-craniotomy in the management of chronic subdural hematoma.
